神経調節の世界市場:予測及び分析 2020-2024

LINEで送る

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
• Value chain analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2019
• Market Outlook
• Market size and forecast 2019-2024
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• Implantable neuromodulation devices – Market size and forecast 2019-2024
• External neuromodulation devices – Market size and forecast 2019-2024
• Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2019-2024
• Europe – Market size and forecast 2019-2024
• Asia – Market size and forecast 2019-2024
• ROW – Market size and forecast 2019-2024
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Improving reimbursement policies
• Strategic collaborations and acquisitions
• Expanding indications
• PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Abbott Laboratories
• Boston Scientific Corp.
• LivaNova Plc
• Medtronic Plc
• NeuroMetrix Inc.
• Neuronetics Inc.
• Nevro Corp.
• Nuvectra Co.
• OMRON Corp.
• Zynex Inc.
PART 14: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO


Exhibit 01: Global healthcare equipment market
Exhibit 02: Segments of global healthcare equipment market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Vendors: Key offerings
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2019
Exhibit 18: Product – Market share 2019-2024 (%)
Exhibit 19: Comparison by product
Exhibit 20: Implantable neuromodulation devices – Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Implantable neuromodulation devices – Year-over-year growth 2020-2024 (%)
Exhibit 22: External neuromodulation devices – Market size and forecast 2019-2024 ($ millions)
Exhibit 23: External neuromodulation devices – Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2019-2024 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America – Market size and forecast 2019-2024 ($ millions)
Exhibit 29: North America – Year-over-year growth 2020-2024 (%)
Exhibit 30: Number of people aged 65 years and above in EU countries in 2005 and 2018 (in millions)
Exhibit 31: Europe – Market size and forecast 2019-2024 ($ millions)
Exhibit 32: Europe – Year-over-year growth 2020-2024 (%)
Exhibit 33: Number of people aged 65 years and above in Asian countries in 2005 and 2018 (in millions)
Exhibit 34: Asia – Market size and forecast 2019-2024 ($ millions)
Exhibit 35: Asia – Year-over-year growth 2020-2024 (%)
Exhibit 36: ROW – Market size and forecast 2019-2024 ($ millions)
Exhibit 37: ROW – Year-over-year growth 2020-2024 (%)
Exhibit 38: Key leading countries
Exhibit 39: Market opportunity
Exhibit 40: Impact of drivers and challenges
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: Abbott Laboratories – Vendor overview
Exhibit 47: Abbott Laboratories – Business segments
Exhibit 48: Abbott Laboratories – Organizational developments
Exhibit 49: Abbott Laboratories – Geographic focus
Exhibit 50: Abbott Laboratories – Segment focus
Exhibit 51: Abbott Laboratories – Key offerings
Exhibit 52: Boston Scientific Corp. – Vendor overview
Exhibit 53: Boston Scientific Corp. – Business segments
Exhibit 54: Boston Scientific Corp. – Organizational developments
Exhibit 55: Boston Scientific Corp. – Geographic focus
Exhibit 56: Boston Scientific Corp. – Segment focus
Exhibit 57: Boston Scientific Corp. – Key offerings
Exhibit 58: LivaNova Plc – Vendor overview
Exhibit 59: LivaNova Plc – Product segments
Exhibit 60: LivaNova Plc – Organizational developments
Exhibit 61: LivaNova Plc – Geographic focus
Exhibit 62: LivaNova Plc – Segment focus
Exhibit 63: LivaNova Plc – Key offerings
Exhibit 64: Medtronic Plc – Vendor overview
Exhibit 65: Medtronic Plc – Business segments
Exhibit 66: Medtronic Plc – Organizational developments
Exhibit 67: Medtronic Plc – Geographic focus
Exhibit 68: Medtronic Plc – Segment focus
Exhibit 69: Medtronic Plc – Key offerings
Exhibit 70: NeuroMetrix Inc. – Vendor overview
Exhibit 71: NeuroMetrix Inc. – Business segments
Exhibit 72: NeuroMetrix Inc. – Organizational developments
Exhibit 73: NeuroMetrix Inc. – Key offerings
Exhibit 74: Neuronetics Inc. – Vendor overview
Exhibit 75: Neuronetics Inc. – Business segments
Exhibit 76: Neuronetics Inc. – Organizational developments
Exhibit 77: Neuronetics Inc. – Geographic focus
Exhibit 78: Neuronetics Inc. – Key offerings
Exhibit 79: Nevro Corp. – Vendor overview
Exhibit 80: Nevro Corp. – Business segments
Exhibit 81: Nevro Corp. – Organizational developments
Exhibit 82: Nevro Corp. – Geographic focus
Exhibit 83: Nevro Corp. – Key offerings
Exhibit 84: Nuvectra Co. – Vendor overview
Exhibit 85: Nuvectra Co. – Business segments
Exhibit 86: Nuvectra Co. – Organizational developments
Exhibit 87: Nuvectra Co. – Geographic focus
Exhibit 88: Nuvectra Co. – Key offerings
Exhibit 89: OMRON Corp. – Vendor overview
Exhibit 90: OMRON Corp. – Business segments
Exhibit 91: OMRON Corp. – Organizational developments
Exhibit 92: OMRON Corp. – Geographic focus
Exhibit 93: OMRON Corp. – Segment focus
Exhibit 94: OMRON Corp. – Key offerings
Exhibit 95: Zynex Inc. – Vendor overview
Exhibit 96: Zynex Inc. – Business segments
Exhibit 97: Zynex Inc. – Organizational developments
Exhibit 98: Zynex Inc. – Key offerings
Exhibit 99: Validation techniques employed for market sizing
Exhibit 100: Definition of market positioning of vendors




※当サイトのレポート紹介カバレッジ
■産業:医療、IT、電子、自動車、産業機械、建設、消費財、食品、化学、材料、エネルギー、金融、サービスなど多様
■地域:世界市場、アジア市場、中国市場、欧州市場、北米市場、中南米市場、中東市場、アフリカ市場など全世界
■レポート種類:市場動向、規模、占有率、トレンド、将来展望、未来予測、業界分析、産業分析、企業分析、事業機会分析、戦略提言など多様